news 2021

« BACK

Pharmacology



Results 1 - 9 of 9.


Health - Pharmacology - 06.10.2021
KU Leuven develops very potent antiviral against dengue
KU Leuven develops very potent antiviral against dengue
Researchers at the KU Leuven Rega Institute and CD3 have developed an ultrapotent inhibitor of the dengue virus, which causes the tropical disease known as dengue.

Pharmacology - Health - 23.07.2021
Important factor in transplant rejection identified
KU Leuven researchers have revealed the importance of a newly identified mechanism of kidney transplant rejection. These results could increase the chances of a successful transplantation in the future. Each year, about 500 people in our country undergo a kidney transplant. 15 to 20% of these patients experience rejection symptoms.

Health - Pharmacology - 22.07.2021
Antibiotics may help to treat melanoma
Antibiotics may help to treat melanoma
Some antibiotics appear to be effective against a form of skin cancer known as melanoma. KU Leuven researchers examined the effect of these antibiotics on patient-derived tumours in mice. Some antibiotics appear to be effective against a form of skin cancer known as melanoma. KU Leuven researchers examined the effect of these antibiotics on patient-derived tumours in mice.

Health - Pharmacology - 25.06.2021
Clinical trial with virtual patients shows great potential
Clinical trial with virtual patients shows great potential
A study involving virtual instead of real patients was as effective as traditional clinical trials in evaluating a medical device used to treat brain aneurysms, according to researchers from the University of Leeds and KU Leuven. Furthermore, the 'virtual' approach required far less time and money. A study involving virtual instead of real patients was as effective as traditional clinical trials in evaluating a medical device used to treat brain aneurysms, according to researchers from the University of Leeds and KU Leuven.

Health - Pharmacology - 19.05.2021
Cardiologist calls for increased prevention of high blood pressure
Cardiologist calls for increased prevention of high blood pressure
Wednesday, May 19, 2021 — The annual World Hypertension Day on 17 May prompted the publication of a review article on hypertension that appears today in the leading journal The Lancet. In this article, Prof Sofie Brouwers, OLV Ziekenhuis Aalst and Vrije Universiteit Brussel, and her colleagues present the current state of affairs regarding arterial hypertension.

Health - Pharmacology - 01.04.2021
VUB provides breakthrough in chronic pain management
Thursday, April 1, 2021 — An international team of experts has provided a breakthrough in the study of chronic pain in rheumatoid arthritis patients. "We discovered that hypersensitivity is often the cause for all kinds of chronic pain. Personalised treatment tailored to the patient offers the solution here,' says VUB professor Jo Nijs, who is in charge of the project.

Health - Pharmacology - 30.03.2021
VIB/VUB-team map immune cells in aggressive brain tumor
Human glioblastoma tumors are aggressive hard-to-treat brain cancers that have a high unmet need for new treatment options. A team of researchers led by Prof. Kiavash Movahedi and Prof. Jo Van Ginderachter (VIB-VUB), in collaboration with colleagues from VIB, VUB, and KU Leuven, have mapped the immune landscape in these glioblastoma tumors.

Health - Pharmacology - 08.02.2021
Scientists switch on tissue repair in inflammatory bowel disease
A method that instructs immune system cells to help repair damaged tissues in the intestine has been developed by researchers at KU Leuven and Seoul National University. This opens the way for more effective treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease. The study was carried out on humans and mice.

Health - Pharmacology - 13.01.2021
Mechanism that causes irritable bowel syndrome
KU Leuven researchers have identified the biological mechanism that explains why some people experience abdominal pain when they eat certain foods. The finding paves the way for more efficient treatment of irritable bowel syndrome and other food intolerances. Up to 20% of the world's population suffers from irritable bowel syndrome (IBS), which causes stomach pain or severe discomfort after eating.